ScinoPharm Taiwan, Ltd.
1789.TW
Price:
$17.3
Market Cap:
$13.68B
ScinoPharm Taiwan, Ltd., together with its subsidiaries, researches and develops, produces, and sells cGMP active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, the United States, Europe, India, rest of Asia, and internationally. The company offers custom synthesis services for biochemistry molecules, such as peptides and nucleic acids; generic API manufacturing services; and outsourcing services. It also provides CRAM services, such as chemistry skill, analytical and regulatory, chemical process development, clinical drug substance, and consulting services for the development and manufacturing of clinical, small-scale, and commercial-stage APIs and intermediates. In...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2011-09-29
Stock Exchange
TAI
Ticker
1789.TW
PE Ratio
[72.08]
ROE
[1.95%]
Current Ratio
[5.34]
Dividend Yield
[2.02%]
Enterprise Value
[11.32B]
Dividend History
The Current Ratio as of December 2025 (TTM) for ScinoPharm Taiwan, Ltd. (1789.TW) is 5.34
According to ScinoPharm Taiwan, Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 5.34. This represents a change of -30.73% compared to the average of 7.71 of the last 4 quarters.
ScinoPharm Taiwan, Ltd. (1789.TW) Historical Current Ratio (quarterly & annually)
How has 1789.TW Current Ratio performed in the past?
The mean historical Current Ratio of ScinoPharm Taiwan, Ltd. over the last ten years is 6.75. The current 5.34 Current Ratio has changed 7.80% with respect to the historical average. Over the past ten years (40 quarters), 1789.TW's Current Ratio was at its highest in in the September 2021 quarter at 11.22. The Current Ratio was at its lowest in in the June 2018 quarter at 2.58.
Average
6.75
Median
7.58
Minimum
2.65
Maximum
10.73
ScinoPharm Taiwan, Ltd. (1789.TW) Current Ratio by Quarter and Year
Discovering the peaks and valleys of ScinoPharm Taiwan, Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 117.97%
Maximum Annual Current Ratio = 10.73
Minimum Annual Increase = -42.32%
Minimum Annual Current Ratio = 2.65
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 8.61 | -1.59% |
| 2023 | 8.75 | 11.15% |
| 2022 | 7.87 | -26.62% |
| 2021 | 10.73 | 24.48% |
| 2020 | 8.62 | 18.21% |
| 2019 | 7.29 | 117.97% |
| 2018 | 3.34 | -42.32% |
| 2017 | 5.80 | 48.94% |
| 2016 | 3.89 | 46.79% |
| 2015 | 2.65 | -3.11% |
ScinoPharm Taiwan, Ltd. (1789.TW) Average Current Ratio
How has 1789.TW Current Ratio performed in the past?
The current Current Ratio of ScinoPharm Taiwan, Ltd. (1789.TW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.41
5-year avg
8.91
10-year avg
6.75
ScinoPharm Taiwan, Ltd. (1789.TW) Current Ratio vs. Peers
How is 1789.TW’s Current Ratio compared to its peers?
ScinoPharm Taiwan, Ltd.’s Current Ratio is greater than YungShin Global Holding Corporation (2.56), greater than Foresee Pharmaceuticals Co., Ltd. (2.92), greater than Ever Supreme Bio Technology Co., Ltd (1.41), greater than Synmosa Biopharma Corporation (2.70), greater than Standard Chem & Pharm Co. Ltd. (2.07), greater than Visco Vision Inc. (1.44), greater than Excelsior Medical Co., Ltd. (1.55), greater than United Orthopedic Corporation (1.74), greater than Tanvex BioPharma, Inc. (2.17), greater than Grape King Bio Ltd (1.47),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.56 | $15.02B | |
| 2.92 | $12.55B | |
| 1.41 | $14.80B | |
| 2.70 | $16.30B | |
| 2.07 | $11.44B | |
| 1.44 | $10.93B | |
| 1.55 | $14.00B | |
| 1.74 | $11.57B | |
| 2.17 | $14.96B | |
| 1.47 | $19.26B |
Build a custom stock screener for ScinoPharm Taiwan, Ltd. (1789.TW) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ScinoPharm Taiwan, Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
ScinoPharm Taiwan, Ltd. (1789.TW) and other stocks custom spreadsheet templates
The easiest way to analyze a company like ScinoPharm Taiwan, Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Current Ratio?
How can you use the Current Ratio?
What is ScinoPharm Taiwan, Ltd.'s Current Ratio?
How is the Current Ratio calculated for ScinoPharm Taiwan, Ltd. (1789.TW)?
What is the highest Current Ratio for ScinoPharm Taiwan, Ltd. (1789.TW)?
What is the 3-year average Current Ratio for ScinoPharm Taiwan, Ltd. (1789.TW)?
What is the 5-year average Current Ratio for ScinoPharm Taiwan, Ltd. (1789.TW)?
How does the current Current Ratio for ScinoPharm Taiwan, Ltd. (1789.TW) compare to its historical average?